Articles 2023

Tahir Khorasanee, section editor and associate at Wakelin & Associates, expresses in poetry what inspires him and so many others to battle injustice and oppression. Human rights and civil liberties are essential to the functioning of a democratic society. Without these, there is no democracy and there is no justice.

The new Impact Assessment Act came into force at the end of summer, changing Canada’s long-standing regime from environmental assessment to impact assessment. Federal decisions to approve projects will now be made after evaluating whether the project is in the “public interest”, replacing the previous test of avoiding “significant adverse environmental effects”. This article explains five things all participants need to know about the new Act as they address its new requirements and processes.

Published on August 1, 2019, the CSA Staff Notice 51-358 Reporting of Climate Change-related Risks, highlights the disclosure obligations of a securities issuer in light of climate change-related issues as they relate to the issuer's MD&A and AIF. This article explains those risks and their impact.

The Impact Assessment Act and two important regulations came into force in August 2019, transferring greater oversight of the federal environmental assessment process to the new Impact Assessment Agency. This article summarizes these oversight powers and how they have changed from the previous regime.

Technology lawyer recommends amendments to Canada’s Directive on Automated Decision-Making to foster responsible use of Artificial Intelligence.

On November 1, 2019, amendments to the Bankruptcy and Insolvency Act and Companies’ Creditors Arrangement Act will come into force. This article anticipates the practical application of the amendments.

This article discusses the importance of effective data governance in our increasingly technological world and introduces data trusts as a potential answer to some of the concerns surrounding data privacy and use.

How will the law protect victims of malicious “deepfake” videos?

The federal government is changing the regulations governing the price of patented medicines. The innovative pharmaceutical industry is fighting back. This article summarizes the proposed changes as well as the associated constitutional challenges.